Skip to main content
Saudi Medical Journal logoLink to Saudi Medical Journal
letter
. 2019 Nov;40(11):1177. doi: 10.15537/smj.2019.11.24575

Comment on: Does sugammadex decrease the severity of agitation and complications in pediatric patients undergoing adenotonsillectomy?

Yong H Kim 1
PMCID: PMC6901774  PMID: 31707417

To the Editor

I have read with interest the research by Korkmaz.1 I am extremely grateful for detailed study in Sakarya, Turkey. I support additional comments about this study especially sugammadex use.

Sugammadex is the innovative drug for reversal of rocuronium. We expect complete recovery from neuromuscular relaxation after sugammadex. However, it has also some side effect. Bradycardia and cardiac arrest is potential risk reported by many documents.2 My hospital experienced cardiac arrest of patient with variant angina after sugammadex administration.3 Therefore, optimal dose with slow injection is mandatory with electrocardiography monitoring for safe use of sugammadex.

Author designed this study that neostigmine and atropine was injected in the train-of-four (TOF) count 2/4. Train-of-four 3/4 or 4/4 is more ideal for more complete recovery from neuromuscular block. This can reduce postoperative complications in Table 4. However, anesthetic time is slightly prolonged for more TOF count.

Reply from the Author

We would like to thank Dr. Yong H. Kim for their interest in our article entitled “Does sugammadex decrease the severity of agitation and complications in pediatric patients undergoing adenotonsillectomy?”1

In response, I would firstly indicate that the study was only enrolled children with an average age of 6. As you know, the pharmacodynamic of the drugs is one of the distinct scientific research areas in pediatric population. Therefore, the timing of neostigmine administration has not been fully understood, which is now being a research of interest for further studies.4 The information given in comments of the author is absolutely accurate; however, the recommendations merely belongs to the adults population, they are neither for pediatric nor geriatric population.

Muge O. Korkmaz

Otolaryngology Department

Havva Sayhan

Mehmet Guven

Anesthesia and Reanimation Department Faculty of Medicine Van Yuzuncuyıl University Sakarya, Turkey

References

  • 1.Korkmaz MO, Sayhan H, Guven M. Does sugammadex decrease the severity of agitation and complications in pediatric patients undergoing adenotonsillectory? Saudi Med J. 2019;40:907–913. doi: 10.15537/smj.2019.9.24485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Hunter JM, Naguib M. Sugammadex-induced bradycardia and asystole:how great is the risk? Br J Anaesth. 2018;121:8–12. doi: 10.1016/j.bja.2018.03.003. [DOI] [PubMed] [Google Scholar]
  • 3.Ko MJ, Kim YH, Kang E, Lee BC, Lee S, Jung JW. Cardiac arrest after sugammadex administration in a patient with variant angina:a case report. Korean J Anesthesiol. 2016;69:514–517. doi: 10.4097/kjae.2016.69.5.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Luo J, Chen S, Min S, Peng L. Reevaluation and update on efficacy and safety of neostigmine for reversal of neuromuscular blockade. Ther Clin Risk Manag. 2018;14:2397–2406. doi: 10.2147/TCRM.S179420. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Saudi Medical Journal are provided here courtesy of Saudi Medical Journal

RESOURCES